Quest Diagnostics (DGX) Free Cash Flow (2009 - 2026)

Quest Diagnostics has reported Free Cash Flow for 18 years, with the latest figure at $459.0 million in Q2 2026.

• Quarterly Free Cash Flow rose 5.28% year-over-year to $459.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 billion (up 10.21% YoY) and the FY2025 annual result came in at $1.4 billion, up 49.5% from the prior year.
• Free Cash Flow rose to $459.0 million in Q2 2026 per DGX's latest filing, from $164.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $459.0 million in Q2 2026 and troughed at -$33.0 million in Q1 2023.
• A 5-year average of $281.6 million and a median of $316.5 million in 2022 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2023 and 2025: Free Cash Flow plunged 107.91% in 2023, then soared 294.0% in 2025.
• Over 5 years, Free Cash Flow stood at $187.0 million in 2022, then soared by 143.32% to $455.0 million in 2023, then declined by 25.05% to $341.0 million in 2024, then fell by 9.97% to $307.0 million in 2025, then surged by 49.51% to $459.0 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $459.0 million, $164.0 million, and $307.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.